7X7-33509-05038
5 vaccinations
6 coded responses
49 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 032 / NH
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-28
Dose 1 — Pfizer-BioNTech
-
2021-02-04
Registered in v-safe
- 2021-02-04
- 2021-02-11
-
2021-02-15
Dose 2 — Pfizer-BioNTech
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · HeadacheAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-22
Health check-in — day 7, dose 2Feeling: Good · Site: Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-05-17
- 2021-08-16
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-10
-
2021-10-11
Health check-in — days 1–6 daily, dose 3Feeling: Good · Fever · Muscle or body achesAdult check-in
- 2021-10-13
- 2021-10-20
-
2021-10-27
Survey response — day 21, dose 3MedDRA: Asthenia, Chills, Fatigue, Hyperhidrosis — Feeling: FairFree text: Weakness, fatigue, chills and sweating.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-03
-
2021-11-12
Survey response — day 35, dose 3MedDRA: Fatigue, Myalgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Muscle pain and fatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-11-17
- 2022-01-05
-
2022-04-06
Survey response — 6 months, dose 3MedDRA: Connective tissue disorder, Fatigue, Headache, Myalgia, Patient isolation, Photophobia, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I think I may have contracted the virus. I had a fever of 101, was in a lot of joint muscle and connective tissue pain, fatigue, headache, and light sensitivity. I isolated myself and recovered within a few days. Fatigue lingers.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-17
Dose 4 — Pfizer-BioNTech
- 2022-05-17
-
2022-05-18
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-20
-
2022-05-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-22
Health check-in — days 1–6 daily, dose 4Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-23
Survey response — days 1–6 daily, dose 4MedDRA: Condition aggravated, Pre-existing disease, Raynaud's phenomenon — Feeling: Fair · Muscle or body achesFree text: Raymauds and GERD have been moderate to severe this past week.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-24
- 2022-05-31
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-06-28
- 2022-08-16
-
2022-09-13
Dose 5 — Pfizer-BioNTech
-
2022-09-21
Survey response — day 7, dose 5MedDRA: Arthralgia, Fatigue, Myalgia, Neuralgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: The day after the shot I had joint, muscle and nerve pain along with fatigue. It went away the next day.MedDRA releases: 2024-11 · check-in free text available
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-12-13
-
2023-03-14
Survey response — 6 months, dose 5MedDRA: Asthenia, Fatigue, Neuralgia, Photophobia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-28 | Pfizer-BioNTech | |
| 2 | 2021-02-15 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-05-17 | Pfizer-BioNTech | No |
| 5 | 2022-09-13 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Weakness, fatigue, chills and sweating.
Release 10 — day 35, dose 3
Symptoms: Muscle pain and fatigue
Release 11 — 6 months, dose 3
Symptoms: I think I may have contracted the virus. I had a fever of 101, was in a lot of joint muscle and connective tissue pain, fatigue, headache, and light sensitivity. I isolated myself and recovered within a few days. Fatigue lingers.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Raymauds and GERD have been moderate to severe this past week.
Release 12 — day 7, dose 5
Systemic reaction (other): The day after the shot I had joint, muscle and nerve pain along with fatigue. It went away the next day.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Connective tissue disorder | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Neuralgia | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Photophobia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Condition aggravated | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Myalgia | · | · | ✓ |
| SRO | Neuralgia | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Raynaud's phenomenon | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release